Cryoablation Efficacious for Cancer Pain, Review Finds
Cryoablation also cuts the need for opioids at 24 hours post-treatment and at 3 months.
Cryoablation
Focal vs Total PCa Cryoablation Better for Sexual Function
Oncologic outcomes are similar for focal and total cryoablation for localized prostate cancer, but patients report significantly better sexual function after focal cryoablation.
Data Support Biopsy Before Renal Cryo
The recurrence group had significantly larger tumors than the no-recurrence group.
Optimal PSA Nadir After Prostate Cryoablation Identified
A PSA nadir below 0.4 ng/mL offers the best long-term biochemical progression-free survival, study shows.
Cryotherapy Is a Viable Choice for High-Grade Prostate Cancer
Men who underwent whole-gland cryoablation had an estimated 5-year biochemical progression-free survival rate of 59.1%.
Salvage Cryo Outcomes Similar After EBRT, Brachytherapy
Study reveals comparable rates of freedom from biochemical failure at 5 years.
Survival Similar with Renal Cryo Techniques
Lapascopic and percutaneous cryoablation for small renal masses are associated with similar survival, researchers say.
Salvage Prostate Cryoablation Promising
Focal and whole-gland approaches may provide alternatives for recurrent PCa after radiotherapy
Laparoscopic Cryoablation Offers Excellent Long-Term Outcomes
Patients who underwent the procedure experienced no significant change in renal function.
